| Primary |
| Constipation |
50.0% |
| Drug Use For Unknown Indication |
25.0% |
| Hypertension |
25.0% |
|
| Infection Parasitic |
50.0% |
| Pigmentation Disorder |
50.0% |
|
| Secondary |
| Constipation |
15.0% |
| Insomnia |
15.0% |
| Pharyngitis |
15.0% |
| Glioblastoma Multiforme |
10.0% |
| Product Used For Unknown Indication |
10.0% |
| Prophylaxis |
10.0% |
| Antifungal Prophylaxis |
5.0% |
| Bipolar I Disorder |
5.0% |
| Gastrooesophageal Reflux Disease |
5.0% |
| Hypomania |
5.0% |
| Schizophrenia |
5.0% |
|
| Accidental Overdose |
25.0% |
| Insomnia |
25.0% |
| Rhabdomyolysis |
25.0% |
| Therapy Cessation |
25.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
25.1% |
| Product Used For Unknown Indication |
16.0% |
| Constipation |
11.5% |
| Hypertension |
6.4% |
| Prophylaxis |
6.2% |
| Pain |
4.7% |
| Depression |
4.0% |
| Insomnia |
3.6% |
| Chronic Hepatitis C |
2.6% |
| Nausea |
2.6% |
| Osteoporosis |
2.3% |
| Gastritis |
2.0% |
| Prostate Cancer |
1.9% |
| Non-small Cell Lung Cancer |
1.9% |
| Supplementation Therapy |
1.8% |
| Diabetes Mellitus |
1.7% |
| Hypercholesterolaemia |
1.6% |
| Medical Diet |
1.5% |
| Arthritis |
1.3% |
| Anxiety |
1.2% |
|
| Vomiting |
11.6% |
| White Blood Cell Count Decreased |
11.6% |
| Death |
7.3% |
| Pyrexia |
6.7% |
| Ileus |
6.1% |
| Tachycardia |
5.5% |
| Interstitial Lung Disease |
4.9% |
| Osteomalacia |
4.9% |
| Somnolence |
4.9% |
| Tremor |
4.9% |
| Haematuria |
3.7% |
| Pneumonia |
3.7% |
| Deep Vein Thrombosis |
3.0% |
| Diverticular Perforation |
3.0% |
| Gastrointestinal Haemorrhage |
3.0% |
| Hyponatraemia |
3.0% |
| Neutropenia |
3.0% |
| Pulmonary Embolism |
3.0% |
| Renal Failure Acute |
3.0% |
| Renal Impairment |
3.0% |
|
